FDA wants more data on Nuvo’s Pennsaid
MISSISSAUGA, Ontario, Feb. 9 (UPI) — Nuvo said Friday it may be required to generate additional data to win U.S. approval for Pennsaid, but it won't include phase 3 trials.
The announcement is based on a recent meeting Nuvo had with the Food and Drug Administration, which in December issued an approvable letter for Pennsaid, […]
Link